Catherine Bollard, MD, associate center director for translational research and innovation at GW Cancer Center, was quoted by Interesting Engineering in an article about her recent study looking at the safety of a cell therapy involving expanding T-cells against HIV.
Interesting Engineering - First Ever HIV Immunotherapy Drug Proven Safe For Use in Humans
Latest News
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce that Mandy K. Cohen, MD, MPH, will be the keynote speaker for the 2025 GW MD Graduation Celebration and Diploma Ceremony on May 18, 2025, in Lisner Auditorium.
Washington, D.C., leaders, joined representatives from Universal Health Services (UHS), the George Washington University School of Medicine and Health Sciences (GW SMHS) and The GW Medical Faculty Associates (GW MFA) April 10, as Mayor Muriel Bowser cut the ribbon on the first new hospital to open…
The occupational therapy doctoral student will represent GW’s Class of 2025, sharing a message of curiosity, authenticity and empowerment.